Johan Bratt

1.9k citations

38 papers · 1.4k indexed · h-index 21

Impact in

Rheumatology top 1%
- Rheumatoid Arthritis Research and Therapies
- Systemic Lupus Erythematosus Research
- Spondyloarthritis Studies and Treatments
Hematology top 2%
- Autoimmune and Inflammatory Disorders Research

Papers in ⓘ

Rheumatology 24
- Rheumatoid Arthritis Research and Therapies 17
- Otitis Media and Relapsing Polychondritis 5
- Systemic Lupus Erythematosus Research 5
Immunology 20
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 11

Co-authors: Sofia Ernestam (14 shared papers)Ronald van Vollenhoven (11 shared papers)Ingemar F. Petersson (8 shared papers)Pierre Geborek (6 shared papers)Jan Palmblad (9 shared papers)Kristina Forslind (3 shared papers)Katerina Chatzidionysiou (2 shared papers)Kristina Albertsson (2 shared papers)
Journals: Annals of the Rheumatic Diseases (6 papers)Scandinavian Journal of Rheumatology (4 papers)Molecular Medicine (2 papers)Scandinavian Journal of Immunology (2 papers)Headache The Journal of Head and Face Pain (2 papers)
Partner nations: Sweden United States Netherlands

In The Last Decade

Johan Bratt

34 papers receiving 1.4k citations

Peers

Countries citing papers authored by Johan Bratt

Since Specialization

Citations

This map shows the geographic impact of Johan Bratt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Bratt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Bratt more than expected).

Fields of papers citing papers by Johan Bratt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Bratt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Bratt. The network helps show where Johan Bratt may publish in the future.

Co-authors

The 25 scholars most cited alongside Johan Bratt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Johan Bratt Line = papers co-authored together Johan Bratt links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 38 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Addition of infliximab compared with addition of sulfasalazine and hydroxychloroquine to methotrexate in patients with early rheumatoid arthritis (Swefot trial): 1-year results of a randomised trial The Lancet ·Ronald van Vollenhoven, Sofia Ernestam, P. Geborek, Ingemar F. Petersson, L Cöster, Eva Waltbrand, Agneta Zickert, J Theander, Å Thörner, Hans-Olov Hellström, Annika Teleman, Christina Dackhammar, F. Akre, Kristina Forslind, Lotta Ljung, Rolf Oding, Katerina Chatzidionysiou, Margareta Wörnert, Johan Bratt	2009	224
2	Conventional combination treatment versus biological treatment in methotrexate-refractory early rheumatoid arthritis: 2 year follow-up of the randomised, non-blinded, parallel-group Swefot trial The Lancet ·Ronald van Vollenhoven, Pierre Geborek, Kristina Forslind, Kristina Albertsson, Sofia Ernestam, Ingemar F. Petersson, Katerina Chatzidionysiou, Johan Bratt	2012	157
3	Predictors of response to methotrexate in early DMARD naïve rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial Annals of the Rheumatic Diseases ·Saedís Saevarsdóttir, Helena Wallin, Maria Seddighzadeh, Sofia Ernestam, Pierre Geborek, Ingemar F. Petersson, Johan Bratt, Ronald van Vollenhoven	2010	149
4	Adalimumab (Humira®) restores clinical response in patients with secondary loss of efficacy from infliximab (Remicade®) or etanercept (Enbrel®): results from the STURE registry at Karolinska University Hospital Scandinavian Journal of Rheumatology ·Marius C. Wick, Sofia Ernestam, Staffan Lindblad, Johan Bratt, Lars Klareskog, Ronald van Vollenhoven	2005	105
5	In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial Annals of the Rheumatic Diseases ·Hamed Rezaei, Saedís Saevarsdóttir, Kristina Forslind, Kristina Albertsson, Helena Wallin, Johan Bratt, Sofia Ernestam, Pierre Geborek, Ingemar F Pettersson, Ronald van Vollenhoven	2011	75
6	Cytokine-induced neutrophil-mediated injury of human endothelial cells The Journal of Immunology ·Johan Bratt, Jan Palmblad	1997	61
7	Fcγ receptor type IIIA genotype and response to tumor necrosis factor α–blocking agents in patients with rheumatoid arthritis Arthritis & Rheumatism ·Alf Kastbom, Johan Bratt, Sofia Ernestam, Jon Lampa, Leonid Padyukov, Peter Söderkvist, Thomas Skogh	2007	51
8	High-Mobility Group Box-1 Protein (HMGB1) Is Increased in Antineutrophilic Cytoplasmatic Antibody (ANCA)-Associated Vasculitis with Renal Manifestations Molecular Medicine ·Annette Bruchfeld, Mårten Wendt, Johan Bratt, Abdul Rashid Qureshi, Sangeeta S. Chavan, Kevin J. Tracey, Karin Palmblad, Iva Gunnarsson	2010	50
9	Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity Scandinavian Journal of Rheumatology ·Nicolas Vuilleumier, Johan Bratt, Reyhane Alizadeh, Tomas Jogestrand, Ingiäld Hafström, Johan Frostegård	2010	49
10	Cost-effectiveness of infliximab versus conventional combination treatment in methotrexate-refractory early rheumatoid arthritis: 2-year results of the register-enriched randomised controlled SWEFOT trial Annals of the Rheumatic Diseases ·Jonas Eriksson, Johan Karlsson, Johan Bratt, Ingemar F. Petersson, Ronald van Vollenhoven, Sofia Ernestam, Pierre Geborek, Martin Neovius	2014	43
11	Maintenance of improvement in spinal mobility, physical function and quality of life in patients with ankylosing spondylitis after 5 years in a clinical trial of adalimumab Lara D. Veeken ·Désirée van der Heijde, Maxime Bréban, D Halter, Gino DiVittorio, Johan Bratt, Fabrizio Cantini, S. Kary, Aileen L. Pangan, H. Küpper, Suchitrita S. Rathmann, Joachim Sieper, Phillip J. Mease	2014	42
12	Etanercept versus etanercept plus methotrexate: a registry-based study suggesting that the combination is clinically more efficacious Arthritis Research & Therapy ·Ronald van Vollenhoven, Sofia Ernestam, Anders Harju, Johan Bratt, Lars Klareskog	2003	36
13	Endogenous Glutamate in Association With Inflammatory and Hormonal Factors Modulates Bone Tissue Resorption of the Temporomandibular Joint in Patients With Early Rheumatoid Arthritis Journal of Oral and Maxillofacial Surgery ·Anna‐Kari Hajati, Per Alstergren, Karin Näsström, Johan Bratt, Sigvard Kopp	2009	34
14	Wegener's granulomatosis is associated with organ-specific antiendothelial cell antibodies Kidney International ·Carolina Holmén, Marta Christensson, E Pettersson, Johan Bratt, Pär Stjärne, Azza Karrar, Suchitra Sumitran–Holgersson	2004	33
15	Biological vs Conventional Combination Treatment and Work Loss in Early Rheumatoid Arthritis JAMA Internal Medicine ·Jonas Eriksson, Martin Neovius, Johan Bratt, Ingemar F. Petersson, Ronald van Vollenhoven, Pierre Geborek, Sofia Ernestam	2013	29
16	The role of nitric oxide in lipoxin A₄‐induced polymorphonuclear neutrophil‐dependent cytotoxicity to human vascular endothelium in vitro Arthritis & Rheumatism ·Johan Bratt, Hans Gyllenhammar	1995	28
17	Cluster Headache Is Not Associated With Signs of a Systemic Inflammation Headache The Journal of Head and Face Pain ·Ingela Nilsson Remahl, Elisabet Waldenlind, Johan Bratt, Karl Ekbom	2000	27
18	Reduction of Temporomandibular Joint Pain after Treatment with a Combination of Methotrexate and Infliximab Is Associated with Changes in Synovial Fluid and Plasma Cytokines in Rheumatoid Arthritis Cells Tissues Organs ·Sigvard Kopp, Per Alstergren, Sofia Ernestam, Silvi Nordahl, Pär Morin, Johan Bratt	2005	26
19	Rituximab in relapsing or refractory ANCA-associated vasculitis: a case series of 16 patients Scandinavian Journal of Rheumatology ·Mårten Wendt, Iva Gunnarsson, Johan Bratt, Annette Bruchfeld	2011	25
20	Effects of anti-rheumatic gold salts on NF-κB mobilization and tumour necrosis factor-alpha (TNF-α)-induced neutrophil-dependent cytotoxicity for human endothelial cells Clinical & Experimental Immunology ·Johan Bratt, John D. Belcher, Gregory M. Vercellotti, Jan Palmblad	2000	24

About Johan Bratt

Johan Bratt is a scholar working on Rheumatology, Immunology, Genetics, Pathology and Forensic Medicine and Hematology, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Rheumatoid Arthritis Research and Therapies (17 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (11 papers), Chronic Lymphocytic Leukemia Research (7 papers), Autoimmune and Inflammatory Disorders Research (6 papers), Cell Adhesion Molecules Research (5 papers), Otitis Media and Relapsing Polychondritis (5 papers), Systemic Lupus Erythematosus Research (5 papers) and Vasculitis and related conditions (4 papers). The work is most often cited by research in Rheumatology (952 citations), Hematology (370 citations), Genetics (290 citations), Immunology (393 citations) and Complementary and Manual Therapy (41 citations). Johan Bratt has collaborated with scholars based in Sweden, United States and Netherlands. Frequent co-authors include Sofia Ernestam, Ronald van Vollenhoven, Ingemar F. Petersson, Pierre Geborek, Jan Palmblad, Kristina Forslind, Katerina Chatzidionysiou, Kristina Albertsson, Helena Wallin and Saedís Saevarsdóttir. Their work appears in journals such as Annals of the Rheumatic Diseases, Scandinavian Journal of Rheumatology, Molecular Medicine, Scandinavian Journal of Immunology and Headache The Journal of Head and Face Pain.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact